Trial Profile
A study evaluating plasma levels of imatinib after switching from Glivec to generic imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (Cml-Cp)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics
- 25 Jul 2018 New trial record